EPIX
ESSA Pharma
EPIX
EPIX
Delisted
EPIX was delisted on the 8th of October, 2025.
59 hedge funds and large institutions have $119M invested in ESSA Pharma in 2022 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 10 increasing their positions, 21 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
59
Holders Change
-11
Holders Change %
-15.71%
% of All Funds
1%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
8
Increased
10
Reduced
21
Closed
19
Calls
$56K
Puts
–
Net Calls
+$56K
Net Calls Change
-$88K
Top Buyers
| 1 |
Morgan Stanley
New York
|
+$6.68M |
| 2 |
PHS
PFM Health Sciences
San Francisco,
California
|
+$3.03M |
| 3 |
JPMorgan Chase & Co
New York
|
+$640K |
| 4 |
Millennium Management
New York
|
+$393K |
| 5 |
HF
HRT Financial
New York
|
+$168K |
Top Sellers
| 1 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
-$2.53M |
| 2 |
WP
Woodline Partners
San Francisco,
California
|
-$2.32M |
| 3 |
Janus Henderson Group
London,
United Kingdom
|
-$1.78M |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
-$1.58M |
| 5 |
BlackRock
New York
|
-$525K |
